Prostate Cancer Biomarker Market

The Prostate Cancer Biomarker market consists of molecular indicators used to identify, stage, and monitor the progression of prostate cancer. The primary customers are hospitals, diagnostic laboratories, academic and research institutes, and biopharmaceutical companies. Key growth is driven by the integration of multi-omics technologies for higher precision, the rising adoption of noninvasive diagnostic techniques like liquid biopsies, and an increasing focus on personalized cancer care.